Previous 10 | Next 10 |
2023-08-01 10:24:36 ET The US FDA has cleared an Investigational New Drug ( IND ) application from Qualigen ( NASDAQ: QLGN ) to conduct a phase 1 trial of QN-302 for solid tumors. The trial of the G-Quadruplex (G4)-selective transcription inhibitor will begin in the second...
Investigational New Drug (IND) clearance transitions Qualigen Therapeutics from preclinical to clinical-stage company and d emonstrates leadership in G4-targeting therapies for areas of high unmet need in oncology CARLSBAD, Calif., Aug. 01, ...
All cash deal with Chembio Diagnostics, a US Subsidiary of the French Diagnostics Company BIOSYNEX, SA, solidifies Qualigen’s strategic priority on therapeutics CARLSBAD, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a therapeutics company focu...
2023-07-18 13:23:21 ET Gainers: Evelo Biosciences ( EVLO ) +34% . Biophytis S.A. ( BPTS ) +30% . The Singing Machine Company ( MICS ) +29% . Hyperfine ( HYPR ) +31% . Advanced Emissions Solutions ( ADES ) +27% . Innodata ( ...
Preclinical Data Show Potential to Overcome Resistance to Key KRAS-G12C Therapeutic Compounds CARLSBAD, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pe...
2023-05-16 09:02:30 ET Qualigen Therapeutics press release ( NASDAQ: QLGN ): Q1 GAAP EPS of -$0.78. Revenue of $1.61M (+123.6% Y/Y). For further details see: Qualigen Therapeutics GAAP EPS of -$0.78, revenue of $1.61M
Company Reports 123% Increase in Year-Over-Year Revenue CARLSBAD, Calif., May 16, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Design...
2023-05-02 17:14:48 ET Qualigen Therapeutics press release ( NASDAQ: QLGN ): Q4 GAAP EPS of -$4.85 misses by $3.60 . Revenue of $5M (-12.3% Y/Y) beats by $3.43M . For further details see: Qualigen Therapeutics GAAP EPS of -$4.85 misses by $3.60, revenue o...
CARLSBAD, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN Qualigen Therapeutics, Inc.), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing di...
Abstracts Feature Preclinical Data in (1) Pancreatic Cancer and (2) Luminal B Breast Cancer CARLSBAD, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments...
News, Short Squeeze, Breakout and More Instantly...
Qualigen Therapeutics Inc. Company Name:
QLGN Stock Symbol:
NASDAQ Market:
Qualigen Therapeutics Inc. Website:
A look at the top 10 most actives in the United States American Rebel Holdings Inc. (AREB) rose 60.3% to $0.83355 on volume of 56,112,820 shares DatChat Inc. (DATS) rose 71.2% to $1.78 on volume of 33,845,116 shares Autonomix Medical Inc. (AMIX) rose 97.4% to $1.22 on volume of 33,054,234...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...